{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:55:12Z","timestamp":1768622112538,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clinbiochem.2023.110604","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:01:29Z","timestamp":1688122889000},"page":"110604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2787-3608","authenticated-orcid":false,"given":"Lee F.","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Manthei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Keren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110604_b0005","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110604_b0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1309\/AJCP4INKZ6LYAQXW","article-title":"Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review","volume":"137","author":"Charafeddine","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110604_b0015","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110604_b0020","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110604_b0025","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00277-020-04162-8","article-title":"Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients","volume":"99","author":"Du","year":"2020","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110604_b0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.5858\/arpa.2020-0794-CP","article-title":"Laboratory detection and initial diagnosis of monoclonal gammopathies","volume":"146","author":"Keren","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2023.110604_b0035","doi-asserted-by":"crossref","unstructured":"Katzmann JA, Kyle RA, Benson J, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009;55(8):1517-1522. 10.1373\/clinchem.2009.126664.","DOI":"10.1373\/clinchem.2009.126664"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0040","doi-asserted-by":"crossref","unstructured":"Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem. 2001;47(4):673-680. 10.1093\/clinchem\/47.4.673.","DOI":"10.1093\/clinchem\/47.4.673"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0045","doi-asserted-by":"crossref","unstructured":"Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002;48(9):1437-1444. 10.1093\/clinchem\/48.9.1437.","DOI":"10.1093\/clinchem\/48.9.1437"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0050","doi-asserted-by":"crossref","unstructured":"Abraham RS, Clark RJ, Bryant SC, et al. Correlation of Serum Immunoglobulin Free Light Chain Quantification with Urinary Bence Jones Protein in Light Chain Myeloma. Clin Chem. 2002;48(4):655-657. 10.1093\/clinchem\/48.4.655.","DOI":"10.1093\/clinchem\/48.4.655"},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110604_b0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative analysis of serum free light chains","volume":"119","author":"Abraham","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110604_b0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05045.x","article-title":"Serum free light chains for monitoring multiple myeloma","volume":"126","author":"Mead","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110604_b0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2004.05169.x","article-title":"Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance","volume":"127","author":"Rajkumar","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110604_b0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1309\/XE3UDARKW1B9EMWM","article-title":"Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins","volume":"124","author":"Bakshi","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clinbiochem.2023.110604_b0075","doi-asserted-by":"crossref","unstructured":"Nowrousian MR, Brandhorst D, Sammet C, et al. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma. Clin. Cancer Res. 2005;11(24):8706-8714. 10.1158\/1078-0432.CCR-05-0486.","DOI":"10.1158\/1078-0432.CCR-05-0486"},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110604_b0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110604_b0085","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/49.8.1252","article-title":"Practical considerations for the measurement of free light chains in serum","volume":"49","author":"Tate","year":"2003","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2023.110604_b0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2006.07.011","article-title":"Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases","volume":"376","author":"Tate","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110604_b0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1258\/000456307782268200","article-title":"Serum free light chains; the need to establish local reference intervals","volume":"44","author":"Pattenden","year":"2007","journal-title":"Ann. Clin. Biochem. Int. J. Lab Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110604_b0100","first-page":"131","article-title":"Quantitative serum free light chain assay \u2013 analytical issues","volume":"30","author":"Tate","year":"2009","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.clinbiochem.2023.110604_b0105","doi-asserted-by":"crossref","unstructured":"Rindlisbacher B, Schild C, Egger F, et al. Serum Free Light Chain Assay: Shift Toward a Higher \u03ba\/\u03bb Ratio. J Appl Lab Med. 2020;5(1):114-125. 10.1093\/jalm.2019.029330.","DOI":"10.1093\/jalm.2019.029330"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0110","doi-asserted-by":"crossref","unstructured":"Murray D, Dispenzieri A, Kumar S, et al. Free Light Chain Assay Drift: Potential for Misdiagnosis? J Appl Lab Med. 2020;5(6):1411-1413. 10.1093\/jalm\/jfaa093.","DOI":"10.1093\/jalm\/jfaa093"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0115","doi-asserted-by":"crossref","unstructured":"Fink SL, Wener MH, Rudolf JW, et al. A universal reference interval for serum immunoglobulins free light chains may be outdated. Clin Chem Lab Med CCLM. Published online May 25, 2023. 10.1515\/cclm-2023-0473.","DOI":"10.1515\/cclm-2023-0473"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0120","unstructured":"College of American Pathologists. Serum Free Light Chains. CAP Laboratory Qualilty Solutions. Surveys and Anatomic Pathology Education Programs. SFLC-A 2022 Participant Survey:2-3."},{"issue":"May","key":"10.1016\/j.clinbiochem.2023.110604_b0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinbiochem.2018.06.003","article-title":"Reference intervals and diagnostic ranges for serum free \u03ba and free \u03bb immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study","volume":"58","author":"Cotten","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2023.110604_b0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clinbiochem.2021.02.008","article-title":"Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines","volume":"92","author":"Morales-Garcia","year":"2021","journal-title":"Clin. Biochem."},{"issue":"19","key":"10.1016\/j.clinbiochem.2023.110604_b0135","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110604_b0140","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2023.110604_b0145","doi-asserted-by":"crossref","unstructured":"Farnsworth CW, Logsdon NM, Hayes JE, Rais R, Willrich MA, Gronowski AM. Limitations of Free Light Chain Assays caused by the Matrix Effect. 2020;(March):311-319. 10.1093\/jalm\/jfz021.","DOI":"10.1093\/jalm\/jfz021"},{"key":"10.1016\/j.clinbiochem.2023.110604_b0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clinbiochem.2022.02.006","article-title":"Comparison of 8 methods for univariate statistical exclusion of pathological subpopulations for indirect reference intervals and biological variation studies","volume":"103","author":"Tan","year":"2022","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2023.110604_b0155","unstructured":"EP28-A3c: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline\u2014third edition. :76."},{"issue":"Suppl. 1","key":"10.1016\/j.clinbiochem.2023.110604_b0160","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"Diabetes","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110604_b0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archinte.1988.00380010040006","article-title":"Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults","volume":"148","author":"Goodman","year":"1988","journal-title":"Arch. Intern. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:01:53Z","timestamp":1757865713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912023001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":33,"alternative-id":["S0009912023001327"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110604","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110604"}}